Public Health Service Task Force (2005) Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. U.S. Department of Health and Human Services, National Institutes of Health, Health Resources and Services Administration, Rockville.
http://www.aidsinfo.nih.gov

has been cited by the following article:

• TITLE: HIV Infection in Pregnancy and the Risk of Gestational Hypertension and Preeclampsia

  AUTHORS: Beatrice Landi, Valeria Bezzeccheri, Brunella Guerra, Mariangela Piemontese, Francesca Cervi, Lucia Cecchi, Eleonora Margarito, Stefano R. Giannubilo, Andrea Ciavattini, Andrea L. Tranquilli

  KEYWORDS: Human Immunodeficiency Virus, Preeclampsia, Gestational Hypertension, African Ethnic Group, Immune Tolerance

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.4 No.5, May 20, 2014

  ABSTRACT: The objective of this study was to evaluate the association between HIV infection and hypertensive disorders of pregnancy, comparing the rates of preeclampsia and gestational hypertension in a HIV-infected pregnant group and in a HIV-negative control pregnant group matched for age and parity. Furthermore, we aimed to compare the rates of hypertensive disorders in a subgroup of HIV-positive and HIV-negative African-American Black women. Patients and Methods: This was a prospective observational cohort study conducted at two University Departments of Obstetrics and Gynecology, Salesi Hospital, Ancona, and Sant’Orsola Hospital, Bologna. The HIV-infected patients’ group consisted of 126 pregnant women; 140 HIV-negative pregnant women matched for age and parity served as controls. Gestational hypertension and preeclampsia were diagnosed according to NHBPEP-ISSHP criteria. Categorical data were analyzed using the Fisher exact test. Statistical significance was set at a p value